Little Green Pharma Ltd (ASX: LGP) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Little Green Pharma Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $39.23 million
P/E Ratio 1.61
Dividend Yield 0.00%
Shares Outstanding 301.76 million
Earnings per share -0.034
Dividend per share N/A
Year To Date Return -10.71%
Earnings Yield 62.11%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Little Green Pharma Ltd (ASX: LGP)
    Latest News

    A man in a horse head mask and suit jumps for joy on a beach.
    Cannabis Shares

    Could ASX cannabis shares be set for a smoking hot rebound?

    ASX cannabis stocks could be set for a strong finish to 2024.

    Read more »

    Man in a cannabis greenhouse looks unhappy and puts his thumb down.
    Cannabis Shares

    Why are these 2 ASX cannabis stocks sputtering today?

    Up 174% in 2023, this ASX cannabis share is giving back some more of its gains today.

    Read more »

    A Cronos Australia farmer and ASX cannabis shares investor stands in a field of cannabis plants and smiles at the camera
    Cannabis Shares

    Could ASX cannabis shares be set for a resurgence?

    The world's legal and medical fraternities are taking small steps forward in the medicinal cannabis movement.

    Read more »

    two men in formal business clothing closely inspect a bud from a cannabis crop.
    Cannabis Shares

    Why ASX cannabis shares just jumped back into the spotlight

    ASX cannabis shares operate in a nation where medical marijuana is legal but recreational use remains broadly forbidden.

    Read more »

    little green pharma share price represented by cannabis leaf character jumping cheerfully
    Cannabis Shares

    Little Green Pharma share price shoots 13% higher after capital raise

    There's considerable excitement in the medicinal cannabis space as Australia becomes the world's first market to recognise psychedelics as medicines.

    Read more »

    A Cronos Australia farmer and ASX cannabis shares investor stands in a field of cannabis plants and smiles at the camera
    Cannabis Shares

    Why did this ASX cannabis share just rocket 46%?

    This cannabis share has been given a major boost by regulators...

    Read more »

    a man wearing old fashioned aviator cap and goggles emerges from the top of a cannon pointed towards the sky. He is holding a phone and taking a selfie.
    Cannabis Shares

    Why are these 2 ASX cannabis shares booming all of a sudden?

    It wasn’t all too long ago that most companies involved in the cultivation and sale of medicinal or recreational marijuana…

    Read more »

    little green pharma share price represented by cannabis leaf character jumping cheerfully
    Cannabis Shares

    Little Pharma shares lift 8% amid appointment of 'highly regarded' director

    Little Green Pharma shares are smoking the market today.

    Read more »

    A flaming orange arrow against a black background demonstrates the rising Pilbara Minerals share price today
    Cannabis Shares

    Why did the Little Green Pharma share price flame 23% higher today?

    Little Green Pharma shares were on fire on Thursday...

    Read more »

    Man holding medical cannabis.
    Cannabis Shares

    ASX cannabis shares in spotlight amid COVID prevention research

    Scientists are casting a wide net in the global fight to contain the pandemic.

    Read more »

    A Cronos Australia farmer and ASX cannabis shares investor stands in a field of cannabis plants and smiles at the camera
    Share Gainers

    Why is the Little Green Pharma (ASX:LGP) share price in the green today?

    A new agreement will see exclusivity of sales and distribution in Greece.

    Read more »

    Cannabis Shares

    Little Green Pharma (ASX:LGP) share price leaps 7% on revenue growth

    Patient demand for medicinal cannabis products has grown in Australia.

    Read more »

    LGP ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Little Green Pharma Ltd

    Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). The company offers LGP-branded medicinal cannabis oil products in the Australian and European markets.

    LGP Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    29 May 2024 $0.13 $0.01 8.00% 30,773 $0.13 $0.13 $0.13
    28 May 2024 $0.13 $0.00 0.00% 20,912 $0.13 $0.13 $0.13
    27 May 2024 $0.13 $0.00 0.00% 123,807 $0.13 $0.13 $0.13
    24 May 2024 $0.13 $-0.01 -7.69% 39,040 $0.13 $0.13 $0.13
    23 May 2024 $0.13 $0.01 8.00% 93,686 $0.13 $0.13 $0.13
    22 May 2024 $0.13 $0.00 0.00% 427,665 $0.13 $0.13 $0.12
    21 May 2024 $0.13 $0.00 0.00% 97,117 $0.13 $0.13 $0.13
    20 May 2024 $0.13 $0.00 0.00% 121,621 $0.13 $0.13 $0.13
    17 May 2024 $0.13 $-0.01 -7.69% 16,032 $0.13 $0.13 $0.13
    16 May 2024 $0.13 $0.00 0.00% 60,410 $0.13 $0.13 $0.13
    15 May 2024 $0.13 $-0.01 -7.41% 183,554 $0.13 $0.14 $0.13
    14 May 2024 $0.14 $0.01 7.69% 122,666 $0.13 $0.14 $0.13
    13 May 2024 $0.13 $0.00 0.00% 19,437 $0.13 $0.14 $0.13
    10 May 2024 $0.13 $-0.01 -7.14% 101,342 $0.13 $0.14 $0.13
    09 May 2024 $0.14 $0.00 0.00% 154,670 $0.14 $0.14 $0.13
    08 May 2024 $0.14 $0.01 7.41% 32,591 $0.14 $0.14 $0.13
    07 May 2024 $0.14 $0.01 8.00% 262,518 $0.13 $0.14 $0.13
    06 May 2024 $0.13 $-0.01 -7.69% 106,525 $0.13 $0.13 $0.13
    03 May 2024 $0.13 $0.00 0.00% 230,497 $0.14 $0.14 $0.13
    02 May 2024 $0.13 $0.00 0.00% 569,370 $0.14 $0.15 $0.13
    01 May 2024 $0.13 $0.00 0.00% 236,840 $0.13 $0.14 $0.13
    30 Apr 2024 $0.13 $0.00 0.00% 75,660 $0.13 $0.13 $0.13

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    15 Apr 2024 Angus Caithness Issued 32,000 $4,480
    Conversion of securities. Typo error
    15 Apr 2024 Angus Caithness Exercise 32,000 $4,480
    Conversion of securities. 4,000,000 Rights, Typo error
    15 Apr 2024 Fleta Solomon Exercise 36,000 $5,040
    Conversion of securities. 4,000,000 Rights
    15 Apr 2024 Fleta Solomon Issued 36,000 $5,040
    Conversion of securities.
    03 Apr 2024 Neale Fong Exercise 35,000 $5,250
    Conversion of securities. 105,000 Retention Share Rights
    03 Apr 2024 Michael Lynch-Bell Buy 70,000 $10,500
    Conversion of securities.
    03 Apr 2024 Neale Fong Buy 35,000 $5,250
    Conversion of securities.
    03 Apr 2024 Michael Lynch-Bell Exercise 70,000 $10,500
    Conversion of securities. 210,000 Retention Share Rights
    27 Sep 2023 Fleta Solomon Issued 1,000,000 $160,000
    Issue of securities. 40,36,000 Rights, As per announcement on 04-10-2023
    27 Sep 2023 Neale Fong Issued 70,000 $11,200
    Issue of securities. 140,000 Retention Share Rights
    27 Sep 2023 Angus Caithness Issued 1,000,000 $160,000
    Issue of securities. 40,32,000 Performance Rights
    27 Sep 2023 Fleta Solomon Issued 277,777 $49,999
    Placement.
    27 Sep 2023 Michael Lynch-Bell Issued 140,000 $22,400
    Issue of securities. 280,000 Retention Share Rights
    27 Sep 2023 Beatriz Banzo Issued 70,000 $11,200
    Issue of securities. 2,20,000 Rights
    07 Jul 2023 Angus Caithness Issued 11,870 $2,967
    Director remuneration. deemed issue price
    07 Jul 2023 Neale Fong Issued 9,251 $2,192
    Director remuneration. deemed issue price
    07 Jul 2023 Michael Lynch-Bell Issued 18,459 $4,374
    Director remuneration. deemed issue price
    30 Jun 2023 Angus Caithness Transfer 3,500,000 $542,500
    Off-market transfer.
    30 Jun 2023 Angus Caithness Transfer 3,500,000 $542,500
    Off-market transfer.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Neale William Fong Non-Executive Director Nov 2018
    Dr Fong is a registered medical practitioner with over 35 years in senior leadership roles in private hospitals, the public health systems, management consulting, academia, health research, aged care and not for profit organisations. Neale is currently CEO of Bethesda Health Care and formerly was Director General of the West Australian Department of Health. Neale is an ASX company director and is currently independent chair of Intelicare. He is a former nonexecutive director of Neurotech International and executive chair of Chrysalis Resources and has been a Fellow of the Australian Institute of Company Directors since 2001. Neale is also Chair of the Company's Risk Committee.
    Mr Angus McDougall Caithness Executive Director Feb 2018
    Mr Caithness is a corporate finance executive and consultant in Australia and international markets. Angus has ASX experience as a non-executive Director of Lindian Resources CFO of Hunnu Coal and Company Secretary for the IPO of Haranga Resources. Following these roles, Angus acted as CFO of Tavan Tolgoi, the owner of the coking coal deposit looking at a US$10bn dual listing in London and Hong Kong prior to the change in the Mongolian government.
    Ms Fleta Jennifer Solomon Chief Executive OfficerManaging Director May 2017
    Ms Solomon drives the strategic vision of the business and as Chief Executive Officer of Little Green Pharma has grown the company from a medicinal cannabis startup to an industry medicinal cannabis brand in Australia and overseas. Fleta has 20 years of experience in corporate and consumer health markets.
    Mr Michael David Lynch-Bell Non-Executive ChairmanNon-Executive Director Nov 2018
    Mr Lynch-Bell is a corporate finance executive and consultant. Michael was appointed on 13 November 2018. His early Ernst and Young career were focused on auditing clients within the oil and gas sectors and later added mining to his portfolio. Michael also led Ernst and Young's UK IPO and Global Natural Resources transaction teams in the Transaction Advisory practice. He has been involved advising companies on fundraising, re-organizations, transactions, corporate governance as well as IPOs.
    Ms Beatriz Vicen Banzo Non-Executive Director Jul 2022
    Ms Banzo Has over 30 years working in the European pharmaceutical industry, Beatriz is an experienced and decorated expert in European pharmaceutical regulatory and quality assurance matters. Prior to joining LGP, Beatriz was the Director of Public Affairs (Market Access and Patient Advocacy), Regulatory and Quality Assurance for Bayer Pharmaceuticals and Consumer Health in Spain, Head of Regulatory Affairs and Permanent Executive Committee Guest at Novartis Pharmaceutical Company.
    Mr Alistair Warren Company Secretary Jul 2020
    -
    Alistair Warren Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 37,923,854 12.69%
    Ubs Nominees Pty Ltd 32,256,846 10.79%
    Ms Fleta Jennifer Solomon 21,559,439 7.20%
    Barbright Australia Pty Ltd <Interquartz Super A/C> 14,420,420 4.82%
    Banquo Consulting Pty Ltd 9,048,000 3.02%
    Bnp Paribas Noms Pty Ltd <Drp> 7,468,464 2.50%
    Cg Nominees (Australia) Pty Ltd 4,147,061 1.39%
    Superhero Securities Limited <Client A/C> 3,728,338 1.25%
    Benoni Pty Ltd <The Mkj Super Fund A/C> 3,582,127 1.20%
    Citicorp Nominees Pty Limited 2,530,219 0.85%
    Paul Frederick Long <The Long A/C> 2,371,691 0.79%
    Mr Angus Caithness 2,239,571 0.75%
    Ms Jenny Lorraine Mckay <J & K Mckay 2,229,746 0.75%
    Mr Damien Matthew Booth <Damien Booth Family A/C> 1,858,639 0.62%
    Jasforce Pty Ltd 1,705,556 0.57%
    Michael D Lynch-Bell 1,669,991 0.56%
    Mr Sean Edward Reid plus Ms Louise Jane Pilkington 1,552,600 0.52%
    Bnp Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> 1,406,174 0.47%
    Jensen Jarrah Pty Ltd 1,369,231 0.46%
    Ms Mary Bernadette Davis 1,240,000 0.41%

    Profile

    since

    Note